Bile acid metabolism and signaling, the microbiota, and metabolic disease
The diversity, composition, and function of the bacterial community inhabiting the human
gastrointestinal tract contributes to host health through its role in producing energy or …
gastrointestinal tract contributes to host health through its role in producing energy or …
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
RM Chakaroun, LM Olsson, F Bäckhed - Nature Reviews Cardiology, 2023 - nature.com
Despite milestones in preventive measures and treatment, cardiovascular disease (CVD)
remains associated with a high burden of morbidity and mortality. The protracted nature of …
remains associated with a high burden of morbidity and mortality. The protracted nature of …
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Tobacco smoking is positively correlated with non-alcoholic fatty liver disease (NAFLD),,,–,
but the underlying mechanism for this association is unclear. Here we report that nicotine …
but the underlying mechanism for this association is unclear. Here we report that nicotine …
Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice
Q Zhao, MY Dai, RY Huang, JY Duan, T Zhang… - Nature …, 2023 - nature.com
Parabacteroides distasonis (P. distasonis) plays an important role in human health,
including diabetes, colorectal cancer and inflammatory bowel disease. Here, we show that …
including diabetes, colorectal cancer and inflammatory bowel disease. Here, we show that …
[HTML][HTML] Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases
B Guan, J Tong, H Hao, Z Yang, K Chen, H Xu… - … Pharmaceutica Sinica B, 2022 - Elsevier
Cardiometabolic disease (CMD), characterized with metabolic disorder triggered
cardiovascular events, is a leading cause of death and disability. Metabolic disorders trigger …
cardiovascular events, is a leading cause of death and disability. Metabolic disorders trigger …
Contribution of specific ceramides to obesity-associated metabolic diseases
P Hammerschmidt, JC Brüning - Cellular and Molecular Life Sciences, 2022 - Springer
Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …
Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids
C Liu, MX Du, LS Xie, WZ Wang, BS Chen… - Nature …, 2024 - nature.com
A strong correlation between gut microbes and host health has been observed in numerous
gut metagenomic cohort studies. However, the underlying mechanisms governing host …
gut metagenomic cohort studies. However, the underlying mechanisms governing host …
Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential
A Zietzer, P Düsing, L Reese, G Nickenig… - … , and Vascular Biology, 2022 - Am Heart Assoc
Growing evidence suggests that ceramides play an important role in the development of
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …
Bile acid and receptors: Biology and drug discovery for nonalcoholic fatty liver disease
T Jiao, Y Ma, X Guo, Y Ye, C Xie - Acta Pharmacologica Sinica, 2022 - nature.com
Nonalcoholic fatty liver disease (NAFLD), a series of liver metabolic disorders manifested by
lipid accumulation within hepatocytes, has become the primary cause of chronic liver …
lipid accumulation within hepatocytes, has become the primary cause of chronic liver …
Macrophage subsets and death are responsible for atherosclerotic plaque formation
H Li, Z Cao, L Wang, C Liu, H Lin, Y Tang… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular diseases, the notorious killer, are mainly caused by atherosclerosis (AS)
characterized by lipids, cholesterol, and iron overload in plaques. Macrophages are effector …
characterized by lipids, cholesterol, and iron overload in plaques. Macrophages are effector …